Cargando...
Reduction of the fluorine-18-labeled fluorodeoxyglucose dose for clinically dedicated breast positron emission tomography
PURPOSE: To determine the clinically acceptable level of reduction in the injected fluorine-18 ((18)F)-labeled fluorodeoxyglucose ((18)F-FDG) dose in dedicated breast positron emission tomography (dbPET). METHODS: A breast phantom with four spheres exhibiting various diameters (5, 7.5, 10, and 16 mm...
Gardado en:
| Publicado en: | EJNMMI Phys |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer International Publishing
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6884607/ https://ncbi.nlm.nih.gov/pubmed/31784863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40658-019-0256-9 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|